跳至主要内容
临床试验/KCT0001832
KCT0001832已完成未知

Human study for investigating the effects of chronic intake of a combined extract of grape and omija on body fat level and related metabolism in obese adults

CJ Cheiljedang0 个研究点目标入组 78 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
20(Year) 至 64(Year)(—)
性别
All

入选标准

  • 1) Subject who voluntarily agree to participate and signs informed consent form
  • 2) 20 years= Age <65 years (= 64years)
  • 3) 25kg/m2= BMI =30kg/m2

排除标准

  • 1) Administration of medicine that affect body weight : appetite suppressants/accelerators, diuretic, beta-blocker, contraceptive, steroid drug, TCA drug, postmenopausal hormone medicine, laxatives, antidepressant et al.
  • 2) Participation in commercial obesity program or experience of calorie-restricted theraphy within three months before the first visit
  • 3) Subject who has consumed of dietary supplements or oritental medicine within one month before the first visit
  • 4) Subject with body weight change more than 3kg within three months before the first visit
  • 5) Subject with surgical experience (esophagogastroplasty, enterectomy, et al.) for weight loss
  • 6) Subject with experience of severe depression (hospital treatment or attempt case)
  • 7) Subject with experience of epilepsy or eating disorder
  • 8) Subject with following disease:
  • - Hypertension
  • - Diabetes(use of hypoglycemic agent) , fasting blood glucose= 180mg/dl
  • - Liver dysfunction (ALT or AST > 80 U/L)
  • - Renal dysfunction (Creatinine > the upper limit of normal level x 1.5)
  • - Hyperthyroidism or hypothyroidism
  • - Malignant tumor, heart diesase, lung diseases, asthma, nerve/mental disorder, stomach and intestines disease, hepatitis, Cushing's disease, tuberculosis
  • 9)Subjects with hypersensitivity to test materials
  • 10) Participation in other human study within one month before the first visit
  • 11) Pregnant or lactating women
  • 12) Subjects with difficult to use smartphone
  • 13) Any condition that the principal investigator believes may put the subjects at undue risk

研究者

发起方
CJ Cheiljedang

相似试验